Literature DB >> 11737031

Emerging role of antileukotriene therapy in allergic rhinitis.

B J Lipworth1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737031     DOI: 10.1046/j.1365-2222.2001.01202.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  5 in total

Review 1.  The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.

Authors:  Malvina Hoxha; G Enrico Rovati; Aurora Bueno Cavanillas
Journal:  Eur J Clin Pharmacol       Date:  2017-04-04       Impact factor: 2.953

2.  Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.

Authors:  D J White; A Vanthuyne; P M Wood; J G Ayres
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

3.  The effects of histamine and leukotriene receptor antagonism on nasal mannitol challenge in allergic rhinitis.

Authors:  Daniel K C Lee; Kay Haggart; Graeme P Currie; Sandra D Anderson; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

Review 4.  Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma.

Authors:  Brian J Lipworth; Catherine M Jackson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Placebo-controlled study with OHIO chamber of prophylactic pranlukast for children with Japanese cedar pollinosis: TOPIC-J III study.

Authors:  Kei Hosoya; Satoru Masuno; Kazuhiro Hashiguchi; Kimihiro Okubo
Journal:  J Drug Assess       Date:  2014-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.